Jeffrey J. Wallin

机构：Gilead Sciences (United States) · ORCID：0000-0002-5952-3813

发表论文 229 篇 · 总被引 6044 次 · h-index 39

代表论文

• Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial (2025 · Nature Communications · 被引 24)
• Changes to inflammatory markers during 5 years of viral suppression and during viral blips in people with HIV initiating different integrase inhibitor based regimens (2024 · Frontiers in Immunology · 被引 11)
• Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liver (2025 · Journal of Clinical Investigation · 被引 9)
• Sociodemographic factors, biomarkers and comorbidities associated with post-acute COVID-19 sequelae in UK Biobank (2025 · Nature Communications · 被引 4)
• A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod (2024 · Infectious Diseases and Therapy · 被引 4)
• AI discovery of TLR agonist-driven phenotypes reveals unique features of peripheral cells from healthy donors and ART-suppressed people living with HIV (2025 · Frontiers in Immunology · 被引 3)